Influence of Lost to Follow Up from Antiretroviral Therapy Among Retroviral Infected Patients at Tuberculosis Centers in Public Hospitals of Benishangul-Gumuz, Ethiopia

References

• Shewangizaw Z, Girma M, Endazenaw G. Assessment of HIV Sero-Prevalence among St. Marry University Students. Ethiopia Sci J Public Health. 2015;3(4):468–477. doi:10.11648/j.sjph.20150304.14
   Google Scholar
• World Health Organization. Consolidated guidelines on the use of ART drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2016.
   Google Scholar
• Central Statistical Agency, and ORC Macro. Ethiopia Demographic and Health Survey 2005. Health San Francisco; September 2006: 446.
   Google Scholar
• Megerso A, Garoma S, Eticha T, et al. Predictors of loss to follow-up in antiretroviral treatment for adult patients in the Oromia region, Ethiopia. HIV AIDS. 2016;8:83–92. doi:10.2147/HIV.S98137
   Google Scholar
• Alvarez-Uria G, Midde M, Pakam R, Naik PK. Predictors of attrition in patients ineligible for antiretroviral therapy after being diagnosed with HIV: data from an HIV Cohort Study in India. Biomed Res Int. 2013;5.
   Google Scholar
• Mohammed F, Assefa N. Determinants of desire for children among HIV-Positive women in the afar region, Ethiopia: case control study. PLoS One. 2016;11:e0150566. doi:10.1371/journal.pone.0150566
   Web of Science ®Google Scholar
• Assefa Y, Kiflie A, Tesfaye D, et al. Outcomes of antiretroviral treatment program in Ethiopia: retention of patients in care is a major challenge and varies across health facilities. BMC Health Serv Res. 2011;11:81. doi:10.1186/1472-6963-11-81
   Web of Science ®Google Scholar
• Hontelez JAC, Chang AY, Ogbuoji O, de Vlas SJ, Bärnighausen T, Atun R. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa. AIDS. 2016;30(15):2341–2350. doi:10.1097/QAD.0000000000001190
   Web of Science ®Google Scholar
• Somi G, Keogh SC, Todd J, et al. Low mortality risk but high loss to follow-up among patients in the Tanzanian national HIV care and treatment programme. Trop Med Int Health. 2012;17(4):497–506. doi:10.1111/j.1365-3156.2011.02952.x
   Web of Science ®Google Scholar
• Berheto TM, Haile DB, Mohammed S. Predictors of loss to follow-up in patients living with HIV/AIDS after initiation of antiretroviral therapy. N Am J Med Sci. 2014;6(9):453–459. doi:10.4103/1947-2714.141636
   PubMedGoogle Scholar
• Deribe K, Hailekiros F, Biadgilign S, Amberbir A, Beyene BK. Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest Ethiopia. Trop Med Int Health. 2008;13(3):328–333. doi:10.1111/j.1365-3156.2008.02006.x
   PubMed Web of Science ®Google Scholar
• Benishangul-Gumuz Region [Internet]. Benishangul-Gumuz Region; 2021. Available from: https://en.wikipedia.org/wiki/Benishangul-Gumuz_Region. Accessed Jan 13, 2021.
   Google Scholar
• Mutasa-Apollo T, Shiraishi RW, Takarinda KC, et al. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe’s National Antiretroviral Therapy Programme, 20072010. PLoS One. 2014;9:e86305. doi:10.1371/journal.pone.0086305
   PubMed Web of Science ®Google Scholar
• Dessalegn M, Tsadik M, Lemma H. Predictors of lost to follow up to antiretroviral therapy in primary public hospital of Wukro, Tigray, Ethiopia: a case control study.”. J AIDS HIV Res. 2015;7:1–9. doi:10.5897/JAHR2014.0315
   Google Scholar
• Endebu T, Deksisa A, Moges T, Kisi T, Ensermu T. Incidence of virological failure and associated factors among adult HIV-Positive patients on first line antiretroviral therapy regimen, Central Ethiopia. Int J HIV/AIDS Prevent Edu Behav Sci. 2018;4(2):44–51.
   Google Scholar
• Etienne M, Burrows L, Osotimehin B, et al. Situational analysis of varying models of adherence support and loss to follow up rates; findings from 27 treatment facilities in eight resource limited countries. Trop Med Int Health. 2010;15(Suppl 1):76–81. doi:10.1111/j.1365-3156.2010.02513.x
   Web of Science ®Google Scholar
• Tweya H, Oboho IK, Gugsa ST, et al. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi. PLoS One. 2018;13(1):e0188488. doi:10.1371/journal.pone.0188488
   PubMed Web of Science ®Google Scholar
• Alvarez-Uria G, Naik PK, Pakam R, et al. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India. Glob Health Action. 2013;6:21682. doi:10.3402/gha.v6i0.21682
   Web of Science ®Google Scholar
• Morowatisharifabad MA, Movahed E, Farokhzadian J, et al. Antiretroviral therapy adherence and its determinant factors among people living with HIV/AIDS: a case study in Iran. BMC Res Notes. 2019;12(1):1–5.
   Web of Science ®Google Scholar
• Ahmed I, Gugsa ST, Lemma S, Demissie M. Predictors of loss to follow-up before HIV treatment initiation in Northwest Ethiopia: a case control study. BMC Public Health. 2013;13. doi:10.1186/1471-2458-13-867
   Web of Science ®Google Scholar
• Setegn T, Takele A, Gizaw T, Nigatu D, Haile D. Predictors of mortality among adult antiretroviral therapy users in southeastern Ethiopia: retrospective cohort study. AIDS Res Treat. 2015;2015:1–8. doi:10.1155/2015/148769
   Google Scholar
• Melaku Z, Lamb MR, Wang C, et al. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study. BMC Public Health. 2015;15. doi:10.1186/s12889-015-1776-4
   Web of Science ®Google Scholar
• Morowatisharifabad MA, Movahed E, Nikooie R, et al. Adherence to medication and physical activity among people living with HIV/AIDS. Iran J Nurs Midwifery Res. 2019;24(5):397–399. doi:10.4103/ijnmr.IJNMR_205_18
   Google Scholar
• Belayneh M, Moges M, Mekonnen E, et al. Do loss to follow-up and death rates from ART care vary across primary health care facilities and hospitals in south ethiopia? A retrospective follow-up study. HIV/AIDS - Res Palliat Care. 2015.
   Google Scholar
• Kebede A, Wabe NT. Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in south west Ethiopia. N Am J Med Sci. 2012;4:67–71. doi:10.4103/1947-2714.93376
   Google Scholar